Thrombophilia Screening: Not So Straightforward

被引:4
|
作者
Moore, Gary W. [1 ,2 ]
机构
[1] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Haemophilia & Thrombophilia Ctr, Specialist Haemostasis Lab, Cambridge, England
[2] Middlesex Univ, Dept Nat Sci, London, England
来源
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2024年 / 50卷 / 08期
关键词
activated protein C resistance; antithrombin; protein C; protein S; thrombophilia; PROTEIN-S DEFICIENCY; FACTOR-V-LEIDEN; DEEP-VEIN THROMBOSIS; PLASMA COAGULATION INHIBITORS; INDUCED SKIN NECROSIS; GENETIC RISK-FACTOR; C RESISTANCE; DEVELOPMENTAL HEMOSTASIS; PROTHROMBIN MUTATION; C4B-BINDING PROTEIN;
D O I
10.1055/s-0044-1786807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although inherited thrombophilias are lifelong risk factors for a first thrombotic episode, progression to thrombosis is multifactorial and not all individuals with inherited thrombophilia develop thrombosis in their lifetimes. Consequently, indiscriminate screening in patients with idiopathic thrombosis is not recommended, since presence of a thrombophilia does not necessarily predict recurrence or influence management, and testing should be selective. It follows that a decision to undertake laboratory detection of thrombophilia should be aligned with a concerted effort to identify any significant abnormalities, because it will inform patient management. Deficiencies of antithrombin and protein C are rare and usually determined using phenotypic assays assessing biological activities, whereas protein S deficiency (also rare) is commonly detected with antigenic assays for the free form of protein S since available activity assays are considered to lack specificity. In each case, no single phenotypic assay is capable of detecting every deficiency, because the various mutations express different molecular characteristics, rendering thrombophilia screening repertoires employing one assay per potential deficiency, of limited effectiveness. Activated protein C resistance (APCR) is more common than discrete deficiencies of antithrombin, protein C, and protein S and also often detected initially with phenotypic assays; however, some centres perform only genetic analysis for factor V Leiden, as this is responsible for most cases of hereditary APCR, accepting that acquired APCR and rare F5 mutations conferring APCR will go undetected if only factor V Leiden is evaluated. All phenotypic assays have interferences and limitations, which must be factored into decisions about if, and when, to test, and be given consideration in the laboratory during assay performance and interpretation. This review looks in detail at performance and limitations of routine phenotypic thrombophilia assays.
引用
收藏
页码:1131 / 1152
页数:22
相关论文
共 50 条
  • [41] Evidence-based indications for thrombophilia screening
    Lindhoff-Last, E.
    Luxembourg, B.
    VASA-JOURNAL OF VASCULAR DISEASES, 2008, 37 (01): : 19 - 30
  • [42] Outcome of thrombophilia screening in young adults with stroke
    vanAverdonk, MJP
    Novakova, IRO
    Keyzer, A
    Verbruggen, HW
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS415 - PS415
  • [43] Gestational vascular complications: screening for congenital thrombophilia?
    Morais, S.
    Laranjeira, C.
    Faria, S.
    Lima, L.
    Lopes, R.
    Pereira, M.
    Moreira, L.
    Oliveira, F.
    Valente, E.
    Cunha, A.
    Braga, J.
    Campos, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 751 - 751
  • [44] Thrombophilia screening revisited: an issue of personalized medicine
    Giuseppe Colucci
    Dimitrios A. Tsakiris
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 618 - 629
  • [45] What is the role of thrombophilia screening in eye disease?
    Mainwaring, J
    Costin, M
    Needham, J
    Lewis, H
    Sandy, C
    Keightley, S
    Morsman, D
    Knight, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 55 - 56
  • [46] Thrombophilia screening in acute stroke - worth the cost?
    Hicken, L.
    Spencer-Lane, B.
    Waldmeyer, W.
    Cooper, J.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 17 - 17
  • [47] Thrombophilia screening revisited: an issue of personalized medicine
    Colucci, Giuseppe
    Tsakiris, Dimitrios A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (04) : 618 - 629
  • [48] Screening for inherited thrombophilia: indications and therapeutic implications
    De Stefano, V
    Rossi, E
    Paciaroni, K
    Leone, G
    HAEMATOLOGICA, 2002, 87 (10) : 1095 - 1108
  • [49] Thrombophilia screening in patients with ocular venous thrombosis
    Alrifai, M.
    Heidinger, K-S
    Fischer, R.
    Zimmermann, A.
    Kemkes-Matthes, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 754 - 754
  • [50] Impact of screening on thrombophilia for patients with venous thrombosis
    Paschôa, AF
    Guillaumon, AT
    INTERNATIONAL ANGIOLOGY, 2006, 25 (01) : 52 - 59